Factors Influencing to Health – Related Quality of Life among Patients with Pulmonary Tuberculosis
Article Sidebar
Main Article Content
Abstract
Purpose: This study aimed to investigate the predictability of duration of illness, treatment system, fatigue, and health behaviors on health-related quality of life among pulmonary tuberculosis patients.
Design: Predictive correlational study design.
Methods: The sample was 129 patients diagnosed with pulmonary tuberculosis and treated with anti-tuberculosis drugs who came for follow up at the Internal Medicine Department, outpatient building at a university hospital in Bangkok. Inclusion criteria included: being new cases, recurrent cases, or relapse cases who were not in the contagious stage and had improved conditions; having a good conscious; being able to communicate Thai; and having no cognitive impairment. Exclusion criteria included: being diagnosed with psychiatric problems and having COVID-19 infected. The instruments used in the study included; 1) The demographic data and illness history form 2) The Revised Piper Fatigue Scale (PFS-12), 3) The Health Behavior Questionnaire, and 4) The Short Form Health Survey 36 (SF-36). Data were analyzed using descriptive statistics and multiple regression analysis.
Main finding: The sample had a mean score of overall health-related quality of life of 63.43 (SD = 19.26) and 38% of them reported that their current health status was similar to that of the previous year. All independent variables could explain 34% of the variances in health-related quality of life among pulmonary tuberculosis patients (R2 = .34). Fatigue was the strongest predictor of health-related quality of life followed by health behavior and duration of illness ( = - .48, p < .001,
= .16, p < .05,
= .15, p < .05), respectively.
Conclusion and recommendation: As fatigue, health behaviors, and duration of illness could predict health-related quality of life among patients with pulmonary tuberculosis, nurses should assess their health-related quality of life and it influencing factors and create programs for reducing fatigue and promoting health behaviors that are tailored to their duration of illness in order to increase the health-related quality of life of patients with pulmonary tuberculosis.
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Copyright Notice: Nursing Science Journal of Thailand has exclusive rights to publish and distribute the manuscript and all contents therein. Without the journal’s permission, the dissemination of the manuscript in another journal or online, and the reproduction of the manuscript for non-educational purpose are prohibited.
Disclaimer: The opinion expressed and figures provided in this journal, NSJT, are the sole responsibility of the authors. The editorial board bears no responsibility in this regard.
References
World Health Organization. Global tuberculosis report 2020. Geneva, Switzerland: WHO; 2021. 232 p.
Division of Tuberculosis, Department of Disease Control, Ministry of Public Health. National tuberculosis control programme guideline, Thailand 2021. Nonthaburi: Division of Tuberculosis; 2021. 217 p. (in Thai).
Chung SJ, Byeon S-J, Choi J-H. Analysis of adverse drug reactions to first-line anti-tuberculosis drugs using the Korea adverse event reporting system. J Korean Med Sci. 2022;37(16):e128. doi: 10.3346/jkms.2022.37.e128.
Aggarwal AN. Quality of life with tuberculosis. J Clin Tuberc Other Mycobact Dis. 2019;17:100121. doi: 10.1016/j.jctube.2019.100121.
Changkaew K, Monchartree P. Multidrug-resistant tuberculosis (MDR-TB) and treatment costs in tuberculosis-clinic, Maharaj Nakhon Ratchasima Hospital 2013-2015. Disease Control Journal. 2020;46(2):173-84. doi: 10.14456/dcj.2020.17. (in Thai).
Anisah SN, Djuwita R, Sudaryo MK. The Influence of social support to the quality of life of tuberculosis patients in Depok, West Java Province, Indonesia. Global Journal of Health Science. 2020;12(12):112-20. doi: 10.5539/gjhs.v12n12p112.
Butte N, Prachuntasen K, Ritmontri T. Factors associated with quality of life among pulmonary tuberculosis patients in Loei province. Journal of the Office of DPC 7 Khon Kaen. 2020;27(3):1-10. (in Thai).
Voranut C, Suggaravetsir P. Factors related to the quality of life among the tuberculosis patients in Thai-Cambodia Border, Buriram province. Journal of the Office of DPC 7 Khon Kaen. 2021;28(1):42-52. (in Thai).
Green LW, Kreuter MW. Health promotion planning: an educational and ecological approach. 3rd ed. Mountain View, CA: Mayfield Publishing; 1999. 621 p.
Qiu L, Tong Y, Yang Q, Sun N, Gong Y, Yin X. Reliability and validity of a smart quality of life scale for patients with tuberculosis. J Public Health. 2020;28(5):575-82. doi: 10.1007/s10389-019-01067-3.
Samuel R, Natesan S, Bangera MK. Quality of life and associating factors in pulmonary tuberculosis patients. Indian J Tuberc. 2022;9 Suppl 2:S627-8. doi: 10.1093/ofid/ofac492.1273.
Szymanska-Chabowska A, Juzwiszyn J, Tański W, Świątkowski F, Kobecki J, Chabowski M. The fatigue and quality of life in patients with chronic pulmonary diseases. Sci Prog. 2021;104(3):368504211044034. doi: 10.1177/00368504211044034.
AlRasheed MM, Al-Aqeel S, Aboheimed GI, AlRasheed NM, Abanmy NO, Alhamid GA, et al. Quality of life, fatigue, and physical symptoms post-COVID-19 condition: a cross-sectional comparative study. Healthcare (Basel). 2023;11(11):1660. doi: 10.3390/healthcare11111660.
Phakdithaithesa K, Suggaravetsiri P. Factors associated quality of life of tuberculosis patients among the Karen Hill Tribes at Thailand–Myanmar border Tak Province. KKU Journal for Public Health Research. 2019;12(3):65-71. (in Thai).
Yadav RK, Kaphle HP, Yadav DK, Marahatta SB, Shah NP, Baral S, Khatri E, Ojha R. Health related quality of life and associated factors with medication adherence among tuberculosis patients in selected districts of Gandaki Province of Nepal. J Clin Tuberc Other Mycobact Dis. 2021;23:100235. doi: 10.1016/j.jctube.2021.100235.
Duan Y, Peiris DLILK, Yang M, Liang W, Baker J, Hu C, et al. Lifestyle behaviors and quality of life among older adults after the first wave of the COVID-19 pandemic in Hubei China. Frontiers Public Health. 2021;9:744514. doi: 10.3389/fpubh.2021.744514.
Kastien-Hilka T, Rosenkranz B, Schwenkglenks M, Bennett BM, Sinanovic E. Association between Health-related quality of life and medication adherence in pulmonary tuberculosis in South Africa. Front Pharmacol. 2017;18(8):1-7. doi: 10.3389/fphar. 2017.00919.
Borson S, Scanlan JM, Chen P, Ganguli M. The Mini-Cog as a screen for dementia: validation in a population-based sample. J Am Geriatr Soc. 2003;51(10):1451-4. doi: 10.1046/j.1532-5415.2003.51465.x.
Trongsakul S, Lambert R, Clark A, Wongpakaran N, Cross J. Development of the Thai version of Mini-Cog, a brief cognitive screening test. Geriatr Gerontol Int. 2015;15(5):594-600. doi: 10.1111/ggi.12318.
Reeve BB, Stover AM, Alfano CM, Smith AW, Ballard-Barbash R, Bernstein L, et al. The Piper Fatigue Scale-12 (PFS-12): psychometric findings and item reduction in a cohort of breast cancer survivors. Breast Cancer Res Treat. 2012;136(1):9-20. doi: 10.1007/s10549-012-2212-4.
Kronkasem A, Wattanakitkrileart D, Pongthavornkamol K, Kanoksin A. Fatigue experience symptom management strategies and functional status in patients with congestive heart failure. Journal of Nursing Science. 2014;32(4):35-42. (in Thai).
Punyathong C. Perceived self-efficacy and health promotive behaviors among tuberculosis patients Udonthanee Hospital [master’s thesis]. Chiang Mai: Chiang Mai University; 2001. 97 p. (in Thai).
Ware Jr JE, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992;30(6):473-83.
Leurmarnkul W, Meetam P. Properties testing of the retranslated SF36 (Thai Version). The Thai Journal of Pharmaceutical Sciences. 2005;29(1-2):69-88. (in Thai).
Gezahegn H, Ibrahim M, Mulat E. Diabetes mellitus and tuberculosis comorbidity and associated factors among Bale Zone Health Institutions, Southeast Ethiopia. Diabetes Metab Syndr Obes. 2020;13(1):3879-86. doi: 10.2147/DMSO.S248054.
Thedthong W, Puwarawuttipanich W, Saneha C, Rongrunguang Y. Factors predicting fatigue in pulmonary tuberculosis patients receiving anti-tuberculosis drugs. Siriraj Med J. 2021;73(3):167-73. doi: 10.33192/Smj.2021.22.
Sari SP, Funna ED, Septini R. Cost-utility analysis of tuberculosis patients with directly observed treatment and self-administered treatment in an army hospital, Indonesia. Pharm Sci Asia. 2020;47(3):253-61. doi: 10.29090/psa.2020.03.019.0019.